FREMONT, CA, May 04, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC Biopharma, Inc. ABVC, a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced it received a US patent certificate, US 11,554,154 B2, for PDC-1421, for the treatment of Major Depressive Disorder (MDD) on…Read More
ABVC BioPharma Receives US Patent Certificate of PDC1421 for the Treatment of Major Depressive Disorder ABVC BioPharma NASDAQABVC
